TB-500
Investigational; no FDA-approved therapeutic indication
Evidence: Very limited human evidence
Administration: No approved route
Read Review →Evidence and regulatory context for peptide-based treatments connected to body composition.
CJC-1295
Investigational hormonal and body-composition research
Evidence: Limited clinical data
Administration: No approved route
Read Review →Ipamorelin
Investigational hormonal and body-composition research
Evidence: Limited human trials
Administration: No approved route
Read Review →Established / approved options
Weight-management therapies may affect body weight within their approved uses, but this page does not make bodybuilding or cosmetic recommendations.
Being researched
CJC-1295 and ipamorelin are unapproved and are not recommended for body-composition use.
How to use this page
Established options appear before experimental compounds. Goal relevance never overrides regulatory status or evidence quality.
Next step
Open the relevant treatment review for sources, risks, contraindications, and evidence gaps.
MyPeptideQuest
Information only. Not medical advice. No dosing or self-treatment instructions are provided.